Manganese superoxide dismutase (MnSOD) polymorphism, α-tocopherol supplementation and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (Finland)

Cancer Causes and Control

Volumn 14, Issue 6, 2003, Pages 513-518

  Woodson, Karen ^a   Tangrea, Joseph A ^a   Lehman, Teresa A ^b   Modali, Ramakrishna ^b   Taylor, Kristin M ^b   Snyder, Kirk ^c   Taylor, Philip R ^a   Virtamo, Jarmo ^d   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BioServe Biotechnologies Ltd   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

tocopherol; Antioxidants; ATBC Study; Manganese superoxide dismutase; Prostate cancer

Indexed keywords

ALANINE; ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; DNA; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL ENZYME; PLACEBO; VALINE;

ADULT; AGED; ARTICLE; BODY MASS; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FINLAND; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SMOKING;

AGED; ALPHA-TOCOPHEROL; ANTIOXIDANTS; BETA CAROTENE; CASE-CONTROL STUDIES; FINLAND; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; RISK FACTORS; SUPEROXIDE DISMUTASE;

EID: 0041733057     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024840823328     Document Type: Article

References (25)

1. Fleshner NE, Klotz LH (1998) Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev 17: 325-330.
2. Ripple MO, Hagopian K, Oberley TD, Schatten H, Weindruch R (1999) Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications. Antioxid Redox Signal 1: 71-81.
3. Schwartz JL, Antoniades DZ, Zhao S (1993) Molecular and biochemical reprogramming of oncogenesis through the activity of prooxidants and antioxidants. Ann NY Acad Sci 686: 262-278.
4. Emerit I (1994) Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis. Free Rad Biol Med 16: 99-109.
5. Fridovich I (1995) Superoxide radical and superoxide dismutases. Ann Rev Biochem 64: 97-112.
6. Wispe JR, Clark JC, Burhans MS, Kropp KE, Korfhagen TR, Whitsett JA (1989) Synthesis and processing of the precursor for human mangano-superoxide dismutase. Biochim Biophys Acta 994: 30-36.
7. Chance B, Sies H, Boveris A (1979) Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527-605.
8. Rosenblum JS, Gilula NB, Lerner RA (1996) On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci USA 93: 4471-4473.
9. Ambrosone CB, Freudenheim JL, Thompson PA, et al. (1999) Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 59: 602-606.
10. Mitrunen K, Sillanpaa P, Kataja V, et al. (2001) Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis 22: 827-829.
11. ATBC Cancer Prevention Study Group (1994) The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029-1035.
12. ATBC Cancer Prevention Study Group (1994) The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 44: 1-10.
13. Woodson K, Ratnasinghe D, Albanes D, et al. (1999) Prevalence of disease-related DNA polymorphisms among participants in a large cancer prevention trial. Eur J Cancer Prev 8: 441-447.
14. Macmillan-Crow LA, Cruthirds DL (2001) Invited review: manganese superoxide dismutase in disease. Free Rad Res 34: 325-336.
15. Costello LC, Franklin RB (2000) The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy. Oncology 59: 269-282.
16. Burdon RH (1995) Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Rad Biol Med 18: 775-794.
17. Li JJ, Oberley LW, St Clair DK, Ridnour LA, Oberley TD (1995) Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene 10: 1989-2000.
18. Church SL, Grant JW, Ridnour LA, et al. (1993) Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci USA 90: 3113-3117.
19. Liu R, Oberley TD, Oberley LW (1997) Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells. Hum Gene Ther 8: 585-595.
20. Yan T, Oberley LW, Zhong W, St Clair DK (1996) Manganese-containing superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts. Cancer Res 56: 2864-2871.
21. Kupelian P, Katcher J, Levin H, Zippe C, Klein E (1996) Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Urology 48: 249-260.
22. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281: 1591-1597.
23. Oberley LW, Buettner GR (1979) Role of superoxide dismutase in cancer: a review. Cancer Res 39: 1141-1149.
24. Soini Y, Vakkala M, Kahlos K, Paakko P, Kinnula V (2001) MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells. J Pathol 195: 156-162.
25. Baker AM, Oberley LW, Cohen MB (1997) Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate 32: 229-233.